Juvederm Voluma with Lido (2x1 ml)

Patients should avoid alcohol 24 hours before and after treatment to prevent excessive vasodilation, bruising, and swelling.

Contraindicated during pregnancy. There are no controlled studies evaluating the safety of dermal fillers in pregnant women.
All elective aesthetic procedures should be postponed until after childbirth.

Inject into the deep dermis or subcutaneous layer using bolus, fanning, or linear threading technique depending on anatomical area and desired projection.
Typical volume per side is 0.5–1 ml, adjusted to clinical indication and symmetry.
Always aspirate prior to injection and administer slowly to minimize the risk of intravascular compromise. Maintain sterile conditions throughout.

Common post-injection reactions include mild redness, swelling, tenderness, or bruising, typically resolving within several days.
Rare but significant adverse effects such as vascular occlusion, blanching, pain, or visual symptoms require immediate medical intervention.
Applying cold compresses and avoiding direct heat or massage for 24–48 hours helps minimize local inflammation.

The filler’s cross-linked hyaluronic acid restores lost facial volume and supports mid-face lifting by binding and retaining water molecules within the tissue.
Its Vycross™ technology combines low- and high-molecular-weight HA chains, enhancing gel durability and resistance to degradation while ensuring a smooth, natural integration into the dermal matrix.
Over time, the product biodegrades gradually without residue, leaving improved skin quality and elasticity.

Cross-linked Hyaluronic Acid (20 mg/ml) and Lidocaine (0.3%) for analgesia and patient comfort.
Non-animal derived HA, formulated with Vycross™ technology to ensure high cohesivity, precision placement, and longevity of results.